[Phenylbutazone, the black 'horse' of the NSAID family?].
de Grauw
J
J
Divisie Veterinaire Volksgezondheid, faculteit Diergeneeskunde, Utrecht.
Lipman
L J A
LJ
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D002273:Carcinogens; D003362:Cost-Benefit Analysis; D005062:European Union; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D007880:Legislation, Drug; D007886:Legislation, Veterinary; D009426:Netherlands; D010653:Phenylbutazone / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002273:Carcinogens; D010653:Phenylbutazone